Mexico is taking another step toward greater transparency in its medical device market as the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) has launched a public digital tool for checking active sanitary registrations. The new Medical Device Sanitary Registry Viewer, which became available on August 20, gives hospitals, distributors, manufacturers and other healthcare stakeholders a centralized way to confirm whether a medical device holds a current authorization in the country.
The move adds another layer of regulatory visibility to a market that has become increasingly important to global healthcare supply chains. Mexico is one of Latin America’s leading medical device manufacturing centers, with a large manufacturing base serving both domestic demand and international markets. For companies involved in medical device contract manufacturing, the ability to verify regulatory status can provide useful information when assessing suppliers, manufacturing partners and products intended for the Mexican market.
The new public registry is particularly relevant for medical device contract manufacturing operations, where manufacturers, brand owners and distributors may work across different companies and facilities. Confirming that a product has an active sanitary registration can help businesses conduct supplier checks before entering commercial arrangements or expanding distribution. It also gives procurement teams and healthcare institutions another source for validating regulatory information supplied by vendors.
COFEPRIS Puts Active Device Registrations Into a Public Digital Platform
According to COFEPRIS, the Medical Device Sanitary Registry Viewer is being introduced in two stages and will receive continuous updates. The agency has emphasized that the information published through the platform is intended to cover registrations that comply with applicable legal requirements.
The decision to make the information publicly accessible is significant because sanitary registrations are not necessarily permanent records. Authorizations can be modified, extended or revoked depending on regulatory circumstances. A regularly updated platform therefore provides greater value than a fixed database that may quickly become outdated.
The first stage also gives registration holders an opportunity to review the information associated with their records. COFEPRIS has established a two-week period during which holders can submit observations using the designated format through the agency’s specified email channel. The review mechanism is intended to help the regulator compare published information with feedback from the companies responsible for the corresponding registrations.
For hospitals and procurement departments, the practical benefit is straightforward. Before purchasing or distributing a medical device, organizations can use the public reference point to check the regulatory status of the product or supplier. Distributors can similarly use the information as part of their compliance processes, while manufacturers can assess the regulatory standing of products and potential commercial partners.
The platform does not appear to replace the broader regulatory documentation or administrative procedures required for medical device operations in Mexico. Instead, its immediate role is to make registration information easier to consult and verify.
Digital Regulatory Reform Adds Momentum to Mexico’s Medical Device Market
The registry comes as COFEPRIS continues a broader push to modernize its regulatory operations. During a national meeting held on August 5 and 6, the commission identified priorities for Mexico’s Federal Sanitary System that included greater alignment of technical criteria, digitalization of procedures and efforts to reduce regulatory backlogs.
The changes follow a reform to Mexico’s General Health Law published in the Official Gazette of the Federation in January 2026. The reform established a framework for coordination between COFEPRIS and state-level sanitary authorities, adding to the institutional changes taking place within the country’s sanitary system.
The public device registry also follows a separate medical device registration framework introduced by COFEPRIS in June. That framework incorporated international recognition pathways and abbreviated review mechanisms for certain products that have already received authorization from recognized foreign regulators. The objective was to facilitate access to products while maintaining regulatory oversight.
Taken together, the developments suggest that Mexico is attempting to address two sides of the medical device market at the same time. Companies may benefit from more efficient routes for obtaining market authorization, while healthcare institutions and the public gain improved access to information about which products have valid registrations.
This balance could become increasingly important as Mexico strengthens its position in international medical device supply chains. The country’s manufacturing sector has attracted companies serving markets across North America and other regions, making regulatory efficiency and transparency relevant not only to domestic healthcare providers but also to international manufacturers and investors.
For medical device contract manufacturing companies, the registry could become a useful part of market-entry and partner due diligence. Manufacturers evaluating Mexican operations may have greater visibility into the regulatory environment, while companies outsourcing production can use public registration information alongside their existing compliance checks.
The broader significance lies in predictability. A regulatory system is easier for businesses to navigate when companies can determine which products have active authorizations and understand how those authorizations are being managed. For Mexico’s medical device industry, the COFEPRIS viewer represents a practical step toward that objective.
As the platform moves beyond its initial implementation stage and its database continues to be updated, its effectiveness will depend largely on the accuracy and timeliness of the information made available. For now, however, the launch gives companies and healthcare institutions a new public reference point at a time when Mexico’s medical device sector is becoming more closely integrated with global manufacturing and supply networks.
refL: https://mexicobusiness.news/health/news/cofepris-launches-public-tool-medical-device-registries
